Abstract
A series of 48 commercial benzaldehydes have been evaluated for their in vitro antibacterial activity against Mycobacterium tuberculosis H37Rv, using the Alamar Blue susceptibility test and the activity expressed as the minimum inhibitory concentration (MIC) in μg/mL. Benzaldehydes 39 and 41 exhibited a significant activity at 3.12 μg/mL. Although commercial benzaldehydes have been largely used by many research groups in search of news TB-drugs, they had not been tested previously against Mycobacterium tuberculosis. This study adds important information to the rational design of new lead anti-TB drugs.
Keywords: Antimycobacterial evaluation, Alamar Blue assay, Benzaldehydes, Cytotoxicity, Drugs, Tuberculosis, Mycobacterium tuberculosis, multidrug-resistant tuberculosis, MDR-TB, drug-resistant tuberculosis, XDR-TB, Rifampin, Isoniazid, Cell Viability Assay, RPMI 1640, DMSO, MABA, BACTEC, SAR, Mosmans's MTT
Letters in Drug Design & Discovery
Title: Evaluation of Substituted Benzaldehydes Against Mycobacterium tuberculosis
Volume: 7 Issue: 10
Author(s): Marcelle de Lima Ferreira, Andre Luis Peixoto Candea, Maria das Gracas Muller de Oliveira Henriques, Maria Cristina Silva Lourenco, Carlos Roland Kaiser and Marcus Vinicius Nora de Souza
Affiliation:
Keywords: Antimycobacterial evaluation, Alamar Blue assay, Benzaldehydes, Cytotoxicity, Drugs, Tuberculosis, Mycobacterium tuberculosis, multidrug-resistant tuberculosis, MDR-TB, drug-resistant tuberculosis, XDR-TB, Rifampin, Isoniazid, Cell Viability Assay, RPMI 1640, DMSO, MABA, BACTEC, SAR, Mosmans's MTT
Abstract: A series of 48 commercial benzaldehydes have been evaluated for their in vitro antibacterial activity against Mycobacterium tuberculosis H37Rv, using the Alamar Blue susceptibility test and the activity expressed as the minimum inhibitory concentration (MIC) in μg/mL. Benzaldehydes 39 and 41 exhibited a significant activity at 3.12 μg/mL. Although commercial benzaldehydes have been largely used by many research groups in search of news TB-drugs, they had not been tested previously against Mycobacterium tuberculosis. This study adds important information to the rational design of new lead anti-TB drugs.
Export Options
About this article
Cite this article as:
de Lima Ferreira Marcelle, Luis Peixoto Candea Andre, das Gracas Muller de Oliveira Henriques Maria, Cristina Silva Lourenco Maria, Roland Kaiser Carlos and Vinicius Nora de Souza Marcus, Evaluation of Substituted Benzaldehydes Against Mycobacterium tuberculosis, Letters in Drug Design & Discovery 2010; 7 (10) . https://dx.doi.org/10.2174/1570180811007010754
DOI https://dx.doi.org/10.2174/1570180811007010754 |
Print ISSN 1570-1808 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-628X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Synthesis and Evaluation of Tetrazole-BasedHydrazone Derivatives Bearing a Pyridine Moiety as Antimicrobial Agents
Letters in Drug Design & Discovery Molecular Docking and Dynamics Simulation Studies of a Dataset of NLRP3 Inflammasome Inhibitors
Recent Advances in Inflammation & Allergy Drug Discovery Choosing Optimal Firstline Helicobacter pylori Therapy: a View from a Region with High Rates of Antibiotic Resistance
Current Pharmaceutical Design A Novel Method for Preparation of Linezolid, (S)-N-((3-(3-Fluoro-4- Morpholinophenyl)-2-Oxo-5-Oxazolidinyl) Methyl) Acetamide
Letters in Organic Chemistry Micelle-based Systems for Pulmonary Drug Delivery and Targeting
Drug Delivery Letters Covid-19: An Update on Clinical Features, Diagnosis, and Treatment Strategies
Coronaviruses Current and Future Chemotherapy for Chagas Disease
Current Medicinal Chemistry The Role of Bacterial Lipopolysaccharides as Immune Modulator in Vaccine and Drug Development
Endocrine, Metabolic & Immune Disorders - Drug Targets The First Kinetic Enzymatic Resolution of Methyl Ester of C75
Letters in Organic Chemistry Epipolythiodioxopiperazines from Fungi: Chemistry and Bioactivities
Mini-Reviews in Medicinal Chemistry Patent Selections
Recent Patents on Anti-Infective Drug Discovery An Efficient and Environmentally Benign Access Towards Synthesis of Novel 1,2,3-Triazolyl-pyrazoline Hybrids
Letters in Organic Chemistry Vitamin D Insufficiency and Diabetes Risks
Current Drug Targets Mutagenicity of N-oxide Containing Heterocycles and Related Compounds: Experimental and Theoretical Studies
Current Topics in Medicinal Chemistry Therapeutic Drugs that Behave as Mechanism-Based Inhibitors of Cytochrome P450 3A4
Current Drug Metabolism Editorial (Thematic Issue: Recent Updates on Biologically Active Heterocycles - Part 2)
Current Organic Chemistry An Overview of Phytotherapeutic Approaches for the Treatment of Tuberculosis
Mini-Reviews in Medicinal Chemistry HIV-Infected Patients and Liver Transplantation: Who, When and Why
Current HIV Research Molecular Hybridization and Preclinical Evaluation of Imines From Para-substituted 4-phenyl 2-amino Thiazole Incorporated with Isatin Analogues as Antitubercular Agents
Anti-Infective Agents Insights into Immunophilin Structure and Function
Current Medicinal Chemistry